CNN: Moderna applies for FDA authorization of its COVID-19 vaccine
First patient enrolled in UC/UC Health Moderna vaccine trial tells his story
Jarelle Marshall, the first patient administered a dose in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience. Marshall received the first dose on August 25, 2020 with a follow up dose about four weeks later.
Jarelle Marshall receives the first dose of the UC/UC Health Moderna COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
When asked by CNN host Don Lemon about what getting a dose was like, Marshall said, "Other than a sore arm I didn't have any really negative side effects. After the second injection, the day after, my temperature rose a couple degrees around 99 for about a day which made me a little nervous. I was checking my temperature every hour or two. But after that, you know, I was fine. I didn't get sick or didn't have any problems."
Marshall also said that one of the reasons he volunteered for the trial was to set an example for his son.
"I always tell my son, what really matters is what you do when people aren't looking."
Watch the entire segment here and read more about the UC/UC Health Moderna vaccine trial here.
Lead photo Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.